“showed a trend”

Early envelope viruses also showed a trend toward increased Maraviroc sensitivity compared to the paired chronic infection variants (median difference 2.7, range 1.7 – 7.6 nM, p =0.06).

Individuals receiving WBRT showed a trend toward lower risk of disease progression (odds ratio: 0.2, p = 0.06) and decreased risk of death (odds ratio: 0.07, p = 0.07).

The use of veteran transportation services showed a trend to decrease the rates of no-shows without reaching statistical significance (7% vs. 14.5%, p = 0.06).

Furthermore, the proportion of participants with a $10% decrease in average lesion area was significantly higher in the CPA group than the placebo group at weeks 3 ( P =0.05) and 6 ( P =0.02), and showed a trend at week 12 ( P =0.06).

In the probe trial, Zbtb20 +/– mice showed a trend ( p = 0.06) toward favoring the target quadrant slightly less than WT mice ( Fig. 8 C ), but no significant differences were found between the groups during this component of the test in target preference index or mean proximity to the original platform location ( Fig. 8 D , E ).

han SEVs and the use post-dilatation is associated with lower survival, while the use of pre-dilatation did not influence survival; (3) however, in regard to the multivariable analysis, survival was impaired by complex CAD, atrial fibrillation, ICU stay, and higher creatinine, while post-dilatation showed a trend towards increased mortality ( p = 0.06), independent of the transprosthetic gradient; and (4) this study included a large number of TAVI platforms (six platforms in total) and there was no heterogeneity in the survival outcomes, while the Portico and Navitor valves were associated with a higher likelihood of permanent pacemaker implantation.

The nonsignificant changes in IL-5 levels were unexpected, although the P value showed a trend ( P = 0.06).

Colonic mRNA expression of IL-23 showed a trend towards a significant reduction in the Fat-1 mouse ( P = 0.06), whereas the expression of IL-23R did not differ between groups ( P = 0.95).

8(L) ; Eu Veh vs Ts2 Veh: + 1.9 pg/mL), while the treatment with TMG showed a trend of decrease in both Eu (Fig. 8(L) ; p = 0.06, Eu Veh vs Eu TMG: − 8.2 pg/mL) and Ts2 animals (Fig. 8(L) ; p = 0.07, Ts2 Veh vs Ts2 TMG: − 7.6 pg/mL) suggesting the potential efficacy of the compound.

In ASC and ACP, no significant differences in ORR, DCR, or TTF between FFX and GnP were noted, while ACC patients showed a trend toward higher ORR with FFX than GnP (61.5 vs. 23.5%, p = 0.06) and significantly more favorable TTF (median 42.3 vs. 21.0 weeks, respectively, p = 0.004).

One combination of the pathogenic mixed treatment did show higher virulence in the mixed compared to the single treatments (B-18245 and B-18247: 1-sample t- test, t = 4.948, df = 3, p = 0.016; Figure 4D ), two showed a trend (B-18243 and B-18245: 1-sample t- test, t = 2.950, df = 3, p = 0.060; B-18245 and B-18246: 1-sample t- test, t = 2.759, df = 3, p = 0.070; Figure 4D ).

Patients with RRMS showed a trend toward lower concentrations of mtDNA compared to SPMS patients (ratio = 0.49, p = 0.06; Supplementary Table 1).

The Robo2 increase was significant ( P ≤0.05, t -test; n =8 LgDel , 12 WT), whereas that for L1Cam showed a trend ( P ≤0.06, t -test).

The ENGENE-PSP study, the largest case-control study of PSP, assigned chemical exposure showed a trend of increased odds (OR = 1.20; 95% CI = 0.99–1.45; p = 0.06), and assigned metal exposure had a trend of increased odds (OR = 1.30; 95% CI = 1.00–1.70; p = 0.05) in the univariate analysis.

Higher pre-FLOT SMI (HR: 0.95, p = 0.09) and tumors in the GEJ ( versus stomach, HR: 0.34, p = 0.07) showed a trend towards superior PFS whereas pre-FLOT sarcopenia ( versus no sarcopenia, HR: 2.83, p = 0.06; Fig. 1 b) showed a trend towards inferior PFS.

While TD showed reward-related activation (gains > losses) in this region overall ( t = 4.86, p = 0.0002) and separately for both Human and Computer runs ( t = 4.37, p = 0.0005 and t = 3.94, p = 0.001, respectively), individuals with ASDs showed a trend for this effect in Computer runs only ( t = 1.62; p = 0.06); Fig. 4 C). 3.2.6.

White race showed a trend toward association with lower HbA1c in the primary analyses (p = 0.06) and was associated with lower mean HbA1c over the prior 12 months in secondary analyses (p = 0.005).

The correlations showed a trend to differ, z =1.89, p =.06 (Fisher's Z-test).

Interestingly, the amount of spatial information contained in spiking activity showed a trend of increase ( p = 0.06) in the hippocampus with MUS in PER in our study (Figure 4D ).

Increases in CBV from baseline to peak plantar flexion exercise after BR placebo and BR nitrate showed a trend for a greater increase in CBV at the peak workload of plantar flexion with BR nitrate ( p = 0.06; Cohen’s d = 0.56).

Multivariable-adjusted analyses In analyses adjusted for 15-additional variables including preoperative limitations in 7 ADLs, compared to patients with loosening/wear/osteolysis, patients with dislocation/fracture/instability/non-union had significantly higher odds (2.2-times; p = 0.002) of moderate-severe ADL limitation at 2-years post-revision THA (Table 3 ); those with failed prior arthroplasty/infection showed a trend towards significance with odds ratio of 1.6 (p = 0.06).

In echocardiographic measurements, OSA patients showed a trend toward thicker IVS ( p = 0.06) and higher TAPSE ( p = 0.07).

There was no significant interaction ( p > 0.05) between group x time in any power and strength outcome, although SJ and EUR showed a trend to significant interaction ( p = 0.06 and p = 0.065, respectively).

Complete case analysis showed a trend for higher urine sEPCR levels at the time of biopsy when severe microcirculatory inflammation was present (p = 0.06) ( figure 6 ).

Stronger Trop-2 immunostaining showed a trend towards significance for overall and progression-free survival (Figure 1B and 1C , p=0.06 and p=0.05, respectively).